VPG:NYSEVishay Precision Group, Inc. Analysis
Data as of 2026-06-07 - not real-time
$117.51
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Vishay Precision Group reported a robust first‑quarter with revenue of $84.4 M, up 18 % YoY, and bookings topping $100 M, pushing gross margin to roughly 39 % – a clear beat on the backdrop of a 17.6 % annual revenue growth rate. The stock is trading at $117.51, well above its DCF‑derived fair value of $21.44 and carries a trailing P/E of 261 versus an industry average of 32, indicating significant overvaluation. Technicals show price comfortably above the 20‑day ($108.65), 50‑day ($75.12) and 200‑day ($47.45) SMAs, supporting a bullish trend, yet the MACD histogram is negative and the signal line is bearish, while RSI sits at 64.4, hinting at near‑overbought conditions. Volume has been decreasing, and the 30‑day volatility spikes above 100 %, compounded by a high beta of 2.54, underscoring elevated market risk.
The company’s fundamentals reveal thin operating margins (0.9 %), modest ROE (1.8 %), and no dividend, limiting income appeal. Despite strong top‑line momentum and diversified exposure across North America, Europe, Israel and Asia, the valuation gap and heightened volatility suggest caution. Investors should weigh the growth narrative against the stark pricing disconnect and the bearish short‑term technical signals before positioning.
The company’s fundamentals reveal thin operating margins (0.9 %), modest ROE (1.8 %), and no dividend, limiting income appeal. Despite strong top‑line momentum and diversified exposure across North America, Europe, Israel and Asia, the valuation gap and heightened volatility suggest caution. Investors should weigh the growth narrative against the stark pricing disconnect and the bearish short‑term technical signals before positioning.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price far above DCF fair value
- bearish MACD signal and high RSI
- elevated volatility and decreasing volume
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- strong revenue and order growth
- improving gross margin
- still significant valuation premium
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- diversified end‑market exposure
- potential for margin expansion
- high beta and price correction risk
Key Metrics & Analysis
Financial Health
Revenue Growth17.60%
Profit Margin1.85%
P/E Ratio261.1
ROE1.82%
ROA1.42%
Debt/Equity13.27
P/B Ratio4.7
Op. Cash Flow$8.5M
Free Cash Flow$9.1M
Industry P/E32.6
Technical Analysis
TrendBullish
RSI64.4
Support$63.45
Resistance$136.21
MA 20$108.65
MA 50$75.12
MA 200$47.45
MACDBearish
VolumeDecreasing
Fear & Greed Index83.02
Valuation
Fair Value$21.44
Target Price$94.67
Upside/Downside-19.44%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.54
Volatility105.68%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.